BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16489506)

  • 1. Limited IL-6 production following infection with murine gammaherpesvirus 68.
    Gasper-Smith N; Singh S; Bost KL
    Arch Virol; 2006 Jul; 151(7):1423-9. PubMed ID: 16489506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis.
    Elsawa SF; Bost KL
    J Immunol; 2004 Jan; 172(1):516-24. PubMed ID: 14688362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine Gammaherpesvirus 68 Pathogenesis Is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production upon Extrinsic Stimulation in Culture.
    Cieniewicz B; Dong Q; Li G; Forrest JC; Mounce BC; Tarakanova VL; van der Velden A; Krug LT
    J Virol; 2015 Jul; 89(13):6562-74. PubMed ID: 25855746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6-deficient mice.
    Sarawar SR; Brooks JW; Cardin RD; Mehrpooya M; Doherty PC
    Virology; 1998 Sep; 249(2):359-66. PubMed ID: 9791027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis.
    Peacock JW; Bost KL
    Immunology; 2001 Sep; 104(1):109-17. PubMed ID: 11576228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent infection by γherpesvirus stimulates profibrotic mediator release from multiple cell types.
    Stoolman JS; Vannella KM; Coomes SM; Wilke CA; Sisson TH; Toews GB; Moore BB
    Am J Physiol Lung Cell Mol Physiol; 2011 Feb; 300(2):L274-85. PubMed ID: 21036917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I Interferons and NK Cells Restrict Gammaherpesvirus Lymph Node Infection.
    Lawler C; Tan CS; Simas JP; Stevenson PG
    J Virol; 2016 Oct; 90(20):9046-57. PubMed ID: 27466430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine gamma-herpesvirus 68 limits naturally occurring CD4+CD25+ T regulatory cell activity following infection.
    Gasper-Smith N; Marriott I; Bost KL
    J Immunol; 2006 Oct; 177(7):4670-8. PubMed ID: 16982906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load.
    Hoegh-Petersen M; Thomsen AR; Christensen JP; Holst PJ
    Vaccine; 2009 Nov; 27(48):6723-30. PubMed ID: 19748577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution to the problem of infection of humans with a murine gammaherpesvirus.
    Mistríková J; Hricová M; Supolíková M
    Acta Virol; 2006; 50(1):71-2. PubMed ID: 16599189
    [No Abstract]   [Full Text] [Related]  

  • 11. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
    Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
    Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetical characterization of isolate MHV-60 of mouse herpesvirus strain 68.
    Pappová M; Stanceková M; Spissáková I; Durmanová V; Mistríková J
    Acta Virol; 2004; 48(2):91-6. PubMed ID: 15462284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of intestinal epithelial cells and development of systemic disease following gastric instillation of murine gammaherpesvirus-68.
    Peacock JW; Bost KL
    J Gen Virol; 2000 Feb; 81(Pt 2):421-9. PubMed ID: 10644841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-27 expression following infection with the murine gammaherpesvirus 68.
    Nelson DA; Tolbert MD; Clemens MG; Bost KL
    Cytokine; 2010 Aug; 51(2):184-94. PubMed ID: 20493722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tachykinins in the host response to murine gammaherpesvirus infection.
    Payne CM; Heggie CJ; Brownstein DG; Stewart JP; Quinn JP
    J Virol; 2001 Nov; 75(21):10467-71. PubMed ID: 11581415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection.
    Weslow-Schmidt JL; Jewell NA; Mertz SE; Simas JP; Durbin JE; Flaño E
    J Virol; 2007 Sep; 81(18):9778-89. PubMed ID: 17626106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononucleosis and antigen-driven T cell responses have different requirements for interleukin-2 signaling in murine gammaherpesvirus infection.
    Molloy M; Zhang W; Usherwood E
    J Virol; 2010 Oct; 84(20):10923-7. PubMed ID: 20686022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine gammaherpesvirus 68 serum antibodies in general human population.
    Hricová M; Mistríková J
    Acta Virol; 2007; 51(4):283-7. PubMed ID: 18197737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I Interferon Signaling to Dendritic Cells Limits Murid Herpesvirus 4 Spread from the Olfactory Epithelium.
    Lawler C; Stevenson PG
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes.
    Ostrowski M; Vermeulen M; Zabal O; Zamorano PI; Sadir AM; Geffner JR; Lopez OJ
    J Virol; 2007 Sep; 81(17):9357-67. PubMed ID: 17567692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.